Protective effects of Lycium barbarum polysaccharide on neonatal rat primary cultured hippocampal neurons injured by oxygen-glucose deprivation and reperfusion

Journal of Molecular Histology

Volumn 43, Issue 5, 2012, Pages 535-542

  Rui, Chen ^a   Yuxiang, Li ^a   Yinju, Hao ^a   Qingluan, Zhu ^a   Yang, Wu ^a   Qipeng, Zhao ^a   Hao, Wang ^a   Lin, Ma ^b   Juan, Liu ^a   Chengjun, Zhao ^a   Yuanxu, Jiang ^a   Yanrong, Wang ^c   Xiuying, Dai ^a   Wannian, Zhang ^d   Tao, Sun ^b   Jianqiang, Yu ^a  

^a NINGXIA MEDICAL UNIVERSITY   (China)

^b Ningxia Key Lab of Craniocerbral Diseases of Ningxia Hui Autonomous Region   (China)

^c Key Laboratory of Fertility Preservation and Maintenance   (China)

^d Ningxia Hui Medicine Modern Engineering Research Center   (China)

Author keywords

Hippocampal neurons; Lycium barbarum polysaccharide (LBP); Neuroprotection; Oxygen glucose deprivation and reperfusion

Indexed keywords

CALCIUM ION; GLUCOSE; GLUTATHIONE PEROXIDASE; LACTATE DEHYDROGENASE; LYCIUM BARBARUM POLYSACCHARIDE; MALONALDEHYDE; NIMODIPINE; OXYGEN; POLYSACCHARIDE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BRAIN NERVE CELL; CALCIUM CELL LEVEL; CELL PROTECTION; CELL VIABILITY; CONCENTRATION RESPONSE; CONFOCAL LASER MICROSCOPY; HIPPOCAMPUS; MITOCHONDRIAL MEMBRANE POTENTIAL; NEUROPROTECTION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; SPECTROPHOTOMETRY;

ANIMALS; CELL SURVIVAL; CELLS, CULTURED; CULTURE MEDIA; DRUGS, CHINESE HERBAL; GLUCOSE; HIPPOCAMPUS; NEURONS; OXYGEN; PROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY;

LYCIUM BARBARUM; RATTUS;

EID: 84871259981     PISSN: 15672379     EISSN: 15672387     Source Type: Journal    
DOI: 10.1007/s10735-012-9420-4     Document Type: Article

References (37)

1. Chang RC, So KF (2008) Use of anti-aging herbal medicine, Lycium barbarum, against aging-associated diseases. What do we know so farCell Mol Neurobiol 28:643-652
2. Du G, Liu L, Fang J (2004) Experimental study on the enhancement of murine splenic lymphocyte proliferation by Lycium barbarum glycopeptide. J Huazhong Univ Sci Technolog Med Sci 24(518-520):527
3. Fein G, Di Sclafani V, Tanabe JL et al (2000) Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease. Neurology 55:1626-1635
4. Gan L, Zhang SH, Liu Q, Xu HB (2003) A polysaccharide-protein complex from Lycium barbarum upregulates cytokine expression in human peripheral blood mononuclear cells. Eur J Pharmacol 471:217-222
5. Gong H, Shen P, Jin L, Xing C, Tang F (2005) Therapeutic effects of Lycium barbarum polysaccharide (LBP) on irradiation or chemotherapy-induced myelosuppressive mice. Cancer Biother Radiopharm 20:155-162
6. Ha KT, Yoon SJ, Choi DY, Kim DW, Kim JK et al (2005) Protective effect of Lycium chinense fruit on carbon tetrachloride-induced hepatotoxicity. J Ethnopharmacol 96:529-535
7. Hai-Yang G, Ping S, Li JI, Chang-Hong X, Fu T (2004) Therapeutic effects of Lycium barbarum polysaccharide (LBP) on mitomycin C(MMC)-induced myelosuppressive mice. J Exp Ther Oncol 4:181-187
8. Heiss WD, Thiel A, Grond M, Graf R (1999) Which targets are relevant for therapy of acute ischemic strokeStroke 30:1486-1489
9. Ho Y-S, So K-F, Chang RC-C (2010) Anti-aging herbal medicine. How and why can they be used in aging-associated neurodegenerative diseasesAgeing Res Rev 9:354-362
10. Honda HM, Korge P, Weiss JN (2005) Mitochondria and ischemia/reperfusion injury. Ann NY Acad Sci 1047:248-258
11. Hou KA (1984) Dictionary of the families and genera of Chinese seed plants, 2nd edn. Science Press, Beijing
12. Iijima T (2006) Mitochondrial membrane potential and ischemic neuronal death. Neurosci Res 55:234-243
13. Iijima T, Mishima T, Tohyama M, Akaqawa K, Iwao Y (2003) Mitochondrial membrane potential and intracellular ATP content after transient experimental ischemia in the cultured hippocampal neuron. Neurochem Int 43:263-269
14. Jing Z, Yang WU, Sun M et al (2012) Protective effects and mechanisms of OSR on primary cultured hippocampus neurons subjected to anoxic injury in neonatal rat. China J Chin Mater Med 37:1
15. Jun-rong ZHU, Yi-fu TAO, Shen LOU, Zi-mei WU (2010) Protective effects of ginsenoside Rb3 on oxygen and glucose deprivationinduced ischemic injury in PC12 cells. Acta Pharmacol Sin 31:273-280
16. Kazda S (1985) Pharmacology of nimodipine, a calcium antagonist with preferential cerebrovascular activity. Neurochirurgia 28: 70-73
17. Kazda S, Towart R (1982) Nimodipine: a new calcium antagonist drug with a preferential cerebrovascular action. Acta Neurochir (Wien) 63:259-265
18. Li XM, Ma YL, Liu XJ (2007) Effect of the Lycium barbarum polysaccharides on age-related oxidative stress in aged mice. J Ethnopharmacol 111:504-511
19. Li S-Y, Yang D, Yeung C-M, Yu W-Y, Chang RC-C et al (2011) Lycium Barbarum polysaccharides reduced neuronal damage, blood-retinal barrier disruption and oxidative stress in retinal ischemia/reperfusion injury. PLoS ONE 6(1):e16380
20. Luo Q, Cai Y, Yan J, Sun M, Corke H (2004) Hypoglycemic and hypolipidemic effects and antioxidant activity of fruit extracts from Lycium barbarum. Life Sci 76:137-149
21. McCord JM, Fridovich I (1969) Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem 244: 6049-6055
22. Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351-358
23. Orrenius S, Zhivotovsky B, Nicotera P (2003) Regulation of cell death: the calcium-apoptosis link. Nat Rev Mol Cell Biol 4: 552-565
24. Peng X, Tian G (2001) Structural characterization of the glycan part of glycoconjugate LbGp2 from Lycium barbarum L. Carbohydr Res 331:95-99
25. Peng X, Huang LJ, Qi CH, Zhang YX, Tian G (2001) Studies on chemistry and immuno-modulating mechanism of a glycoconjugate from Lycium barbarum L. Chin J Chem 19:1190-1197
26. Reers M, Smith TW, Chen LB (1991) J-aggregate formation of a carbocyanine as a quantitative fluorescent indicator of membrane potential. Biochemistry 30(18):4480-4486
27. Schaller B, Graf R (2004) Cerebral ischemia and reperfusion: the pathophysiologic concept as a basis for clinical therapy. J Cereb Blood Flow Metab 24(4):351-371
28. Scriabine A, van den Kerckhoff W (1988) Pharmacology of nimodipine. A review. Ann NY Acad Sci 522:698-706
29. Shao-Ping Lu, Pin-Ting Zhao (2010) Chemical characterization of Lycium barbarum polysaccharides and their reducing myocardial injury in ischemia/reperfusion of rat heart. Int J Biol Macromol 47:681-684
30. Szeto HH (2006) Mitochondria-targeted peptide antioxidants: novel neuroprotective agents. AAPS J 8:E521-E531
31. Towart R, Perzborn E (1981) Nimodipine inhibits carbocyclic thromboxane-induced contractions of cerebral arteries. Eur J Pharmacol 69:213-215
32. Towart R, Wehinger E, Meyer H, Kazda S (1982) The effects of nimodipine, its optical isomers and metabolites on isolated vascular smooth muscle. Arzneimittelforschung 32:338-346
33. Wadworth AN, McTavish D (1992) Nimodipine. A review of its pharmacological properties, and therapeutic efficacy in cerebral disorders. Drugs Aging 2:262-286
34. Wang Y, Zhao H, Sheng X, Gambino PE, Costello B, Bojanowski K (2002) Protective effect of Fructus Lycii polysaccharides against time and hyperthermia-induced damage in cultured seminiferous epithelium. J Ethnopharmacol 82:169-175
35. Wong CK, Leung KN, Fung KP, Choy YM (1994) Immunomodulatory and anti-tumour polysaccharides from medicinal plants. J Int Med Res 22:299-312
36. Yu MS, Lai CS, Ho YS, Zee SY, So KF et al (2007) Characterization of the effects of anti-aging medicine Fructus lycii on betaamyloid peptide neurotoxicity. Int J Mol Med 20:261-268
37. Zhu XJ, Shi Y, Peng J, Guo CS, Shan NN, Qin P, Ji XB, Hou M (2009) The effects of BAFF and BAFF-R-Fc fusion protein in immune thrombocytopenia. Blood 114(26):5362-5367